CohBar Completes Phase 1a and Initiates Phase 1b Stage of Clinical Trial of CB4211 Under Development for NASH and Obesity Nov 5, 2019
CohBar to Announce 2019 Third Quarter Financial Results and Provide Business Update on November 6, 2019 Oct 24, 2019
CohBar to Announce 2019 Second Quarter Financial Results and Provide Business Update on August 7, 2019 Jul 31, 2019
CohBar poster available on preclinical results showing efficacy of a new family of mitochondria based therapeutics in a type 2 diabetes model as presented at the American Diabetes Association 79th Scientific Sessions Jun 10, 2019
CohBar to Present Data on Novel Analogs of a Mitochondrially Encoded Peptide with Beneficial Effects in an Animal Model of Type 2 Diabetes at the American Diabetes Association 79th Scientific Sessions May 29, 2019
